|
Volumn 49, Issue 2, 1999, Pages 133-136
|
Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats
a,b a,b a,b a,b a,b a,b a,b a,b a,b |
Author keywords
Antidiabetic agents; CAS 172647 53 9; DRF 2189, pharmacokinetics, rats; Insulin sensitizers; Thiazolidinediones; 5 4 2 (1 Indolyl)ethoxy phenyl methyl thiazolidine 2,4 dione
|
Indexed keywords
5 [4 [2 (1 INDOLYL)ETHOXY]BENZYL] 2,4 THIAZOLIDINEDIONE;
ANTIDIABETIC AGENT;
ROSIGLITAZONE;
TROGLITAZONE;
UNCLASSIFIED DRUG;
[5 [4 [2 (1 INDOLYL)ETHOXY]PHENYL]METHYL]THIAZOLIDINE 2,4 DIONE;
ADOLESCENT;
AREA UNDER THE CURVE;
ARTICLE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG HALF LIFE;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PLASMA CLEARANCE;
RAT;
|
EID: 0033054894
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0031-1300373 Document Type: Article |
Times cited : (3)
|
References (11)
|